1 Day
Source:
مأرب برس
Al-Arada cites external influence in Hadramout
Reports have indicated that the European pharmaceutical company "Sinopharm" plans to launch a COVID-19 vaccine in 2026, after completing the second phase of clinical trials and beginning the third phase. This announcement is part of efforts to develop a long-lasting vaccine to combat the pandemic and reduce reliance on existing vaccines.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)